Anwar Haque
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Anwar Haque has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Naveed Ur Rehman Siddiqui
Department of Pediatric and Child Health, Aga Khan University Hospital, Karachi, Pakistan
2 shared publications - Chase P. Rupprecht
Geisel Sch Med Dartmouth, Dartmouth Hitchcock Med Ctr, Lebanon, NH 03756 USA
1 shared publication D. Rana
1 shared publication- Guha Krishnaswamy
Wake Forest School of Medicine, Winston-Salem, North Carolina, USA
1 shared publication - Laila Ladak
The Aga Khan University School of Nursing and Midwifery, Karachi, Pakistan
1 shared publication - Madiha Ariff
Internal Medicine, Dow University of Health Sciences, Karachi, PAK
1 shared publication
Latest Publications
- 9 November 2023
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 131 (5) , S131-S132
THE CONUNDRUM OF DISABLING SEVERE DELAYED PRESSURE URTICARIA AND THE EFFICACY OF OMALIZUMAB
- 9 November 2023
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 131 (5) , S131-S132
THE CONUNDRUM OF DISABLING SEVERE DELAYED PRESSURE URTICARIA AND THE EFFICACY OF OMALIZUMAB
- Open Access
- 28 March 2020
- Published by Springer Nature in Cureus
- Vol. 12 (3) , e7442
Safety and Efficacy of Procedural Sedation and Analgesia in Pediatric Oncology Patients
Procedural sedation and analgesia are the standard of care for painful procedures in children that require immobility. The aim is to assess the safety and efficacy of procedural sedation and analgesia in pediatric oncological patients in a large tertiary care hospital. An observational study performed to review medical records of children who received procedural sedation and analgesia (PSA) for pediatric oncological procedures from July 2018 to September 2018. Patients undergoing oncology procedures (lumbar puncture, intrathecal chemotherapy, bone marrow aspiration +/- trephine) were included, and non-anesthesiologist (intensive care physician/emergency physician certified in pediatric advanced life support) provided PSA. Patients were assessed according to PSA protocol guidelines by the American Society of Anesthesiology (ASA). Low-dose ketamine (0.5 mg/kg) and propofol (2 mg/kg) were administered. A total of 565 children underwent 1216 procedures in whom the median age was 7.4 years, and the majority (65.1%) were males. The most common procedure was the lumbar puncture (n = 956; 78.6%) followed by bone marrow aspirate only (n = 137, 11.3%) and both (n = 123, 10.1%). Eight (0.7%) patients developed transient oxygen desaturation only as an adverse effect of ketamine-propofol drug combination with 50% procedures utilizing propofol 1 mg/kg for sedation. According to the results of our study, the majority of the pediatric patients responded and reported no adverse events during the procedure with ketamine and propofol. Therefore, we conclude that ketamine and propofol are safe and effective as both sedative and an analgesic in procedures on pediatric oncology patients.
- 28 March 2020
- Published by Springer Nature in Cureus
- Vol. 12 (3) , e7442
Open AccessSafety and Efficacy of Procedural Sedation and Analgesia in Pediatric Oncology Patients
Procedural sedation and analgesia are the standard of care for painful procedures in children that require immobility. The aim is to assess the safety and efficacy of procedural sedation and analgesia in pediatric oncological patients in a large tertiary care hospital. An observational study performed to review medical records of children who received procedural sedation and analgesia (PSA) for pediatric oncological procedures from July 2018 to September 2018. Patients undergoing oncology procedures (lumbar puncture, intrathecal chemotherapy, bone marrow aspiration +/- trephine) were included, and non-anesthesiologist (intensive care physician/emergency physician certified in pediatric advanced life support) provided PSA. Patients were assessed according to PSA protocol guidelines by the American Society of Anesthesiology (ASA). Low-dose ketamine (0.5 mg/kg) and propofol (2 mg/kg) were administered. A total of 565 children underwent 1216 procedures in whom the median age was 7.4 years, and the majority (65.1%) were males. The most common procedure was the lumbar puncture (n = 956; 78.6%) followed by bone marrow aspirate only (n = 137, 11.3%) and both (n = 123, 10.1%). Eight (0.7%) patients developed transient oxygen desaturation only as an adverse effect of ketamine-propofol drug combination with 50% procedures utilizing propofol 1 mg/kg for sedation. According to the results of our study, the majority of the pediatric patients responded and reported no adverse events during the procedure with ketamine and propofol. Therefore, we conclude that ketamine and propofol are safe and effective as both sedative and an analgesic in procedures on pediatric oncology patients.
- 1 May 2014
- Published by Wolters Kluwer Health in Pediatric Critical Care Medicine
- Vol. 15, 65
ABSTRACT 276: A NATIONAL SURVEY OF PEDIATRIC INTENSIVE CARE UNITS IN PAKISTAN
- 1 May 2014
- Published by Wolters Kluwer Health in Pediatric Critical Care Medicine
- Vol. 15, 65
ABSTRACT 276: A NATIONAL SURVEY OF PEDIATRIC INTENSIVE CARE UNITS IN PAKISTAN
- Open Access
- 13 December 2011
- Published by Journal of Infection in Developing Countries in The Journal of Infection in Developing Countries
- Vol. 6 (05) , 416-421
Healthcare-associated infections among pediatric oncology patients in Pakistan: risk factors and outcome
Introduction: Pediatric oncology patients are at increased risk of contracting healthcare-associated infections (HAIs), which are responsible for increased morbidity and mortality rates as well as treatment costs. This study aimed to identify the frequency of HAIs among pediatric oncology patients and their outcome. Methodology: Pediatric oncology patients admitted between January 2009 and June 2010 in a pediatric ward at Aga Khan University Hospital, Karachi, Pakistan, who developed HAIs, were analyzed. Results: A total of 90 HAIs were identified in 32 patients in 70 admissions. The HAI rate among pediatric oncology patients was 3.1/100 admission episodes. Bloodstream infections (63 episodes, 90.0%) were the most common, followed by urinary tract infection (two episodes, 2.9%). Gram-positive infections were seen in 54 (60%) patients, followed by Gram-negative infection in 34 (37.8%), and fungi in 2 (2.8%) cases. Coagulase negative staphylococci was the most common Gram-positive and Escherichia coli and Pseudomonas aeruginosa were most common Gram-negative infections. Mortality rate among pediatric oncology patients who developed HAIs was 12.5% (4/32). Total parental nutrition use and length of stay longer than 30 days were the identified risk factors associated with increased mortality among pediatric oncology patients who developed HAIs. Conclusion: We report an HAI rate among pediatric oncology patients of 3.1/100 admission episodes with a mortality rate of 12.5% in Pakistan. Further studies should be done, especially in the developing world, to identify the risk factors associated with increased mortality among pediatric oncology patients so that adequate measures can be taken to reduce the mortality among these patients.
- 13 December 2011
- Published by Journal of Infection in Developing Countries in The Journal of Infection in Developing Countries
- Vol. 6 (05) , 416-421
Open AccessHealthcare-associated infections among pediatric oncology patients in Pakistan: risk factors and outcome
Introduction: Pediatric oncology patients are at increased risk of contracting healthcare-associated infections (HAIs), which are responsible for increased morbidity and mortality rates as well as treatment costs. This study aimed to identify the frequency of HAIs among pediatric oncology patients and their outcome. Methodology: Pediatric oncology patients admitted between January 2009 and June 2010 in a pediatric ward at Aga Khan University Hospital, Karachi, Pakistan, who developed HAIs, were analyzed. Results: A total of 90 HAIs were identified in 32 patients in 70 admissions. The HAI rate among pediatric oncology patients was 3.1/100 admission episodes. Bloodstream infections (63 episodes, 90.0%) were the most common, followed by urinary tract infection (two episodes, 2.9%). Gram-positive infections were seen in 54 (60%) patients, followed by Gram-negative infection in 34 (37.8%), and fungi in 2 (2.8%) cases. Coagulase negative staphylococci was the most common Gram-positive and Escherichia coli and Pseudomonas aeruginosa were most common Gram-negative infections. Mortality rate among pediatric oncology patients who developed HAIs was 12.5% (4/32). Total parental nutrition use and length of stay longer than 30 days were the identified risk factors associated with increased mortality among pediatric oncology patients who developed HAIs. Conclusion: We report an HAI rate among pediatric oncology patients of 3.1/100 admission episodes with a mortality rate of 12.5% in Pakistan. Further studies should be done, especially in the developing world, to identify the risk factors associated with increased mortality among pediatric oncology patients so that adequate measures can be taken to reduce the mortality among these patients.